Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

292 results about "Lymph fluid" patented technology

Lymph is the fluid that circulates throughout the lymphatic system. It is formed when the interstitial fluid (the fluid which lies in the interstices of all body tissues) is collected through lymph capillaries.

Microneedle device for extraction and sensing of bodily fluids

Microneedle devices are provided for controlled sampling of biological fluids in a minimally-invasive, painless, and convenient manner. The microneedle devices permit in vivo sensing or withdrawal of biological fluids from the body, particularly from or through the skin or other tissue barriers, with minimal or no damage, pain, or irritation to the tissue. The microneedle device includes one or more microneedles, preferably in a three-dimensional array, a substrate to which the microneedles are connected, and at least one collection chamber and / or sensor in communication with the microneedles. Preferred embodiments further include a means for inducing biological fluid to be drawn through the microneedles and into the collection chamber for analysis. In a preferred embodiment, this induction is accomplished by use of a pressure gradient, which can be created for example by selectively increasing the interior volume of the collection chamber, which includes an elastic or movable portion engaged to a rigid base. Preferred biological fluids for withdrawal and / or sensing include blood, lymph, interstitial fluid, and intracellular fluid. Examples of analytes in the biological fluid to be measured include glucose, cholesterol, bilirubin, creatine, metabolic enzymes, hemoglobin, heparin, clotting factors, uric acid, carcinoembryonic antigen or other tumor antigens, reproductive hormones, oxygen, pH, alcohol, tobacco metabolites, and illegal drugs.
Owner:GEORGIA TECH RES CORP +1

Measurement of body compounds

The present invention provides a method for identifying a concentration of a compound within a part of a subject. The method involves measuring the amount of electromagnetic radiation reflected by, or transmitted through the part with a detector, and using a quantitative mathematical analysis to determine the concentration of the compound in one, or more than one compartment, including a blood, interstitial, cellular, lymph, or bone compartment, of the part. A corrected concentration of the compound may be then determined within a compartment of interest, or a total concentration of the compound may be accurately determined. Preferably, the compound is glucose. From this determination, a clinical condition in a human or animal may be made by correlating the concentration of a measured compound in the compartment of a part of the human or animal to a clinical condition in need of treatment.
Owner:TYCO HEALTHCARE GRP LP

Lymphedema treatment system

A method of body manipulation in furtherance of treating lymphedema is provided. A wrap, adapted to fit about a body extremity and having a trunk region, and limb regions, and a plurality of compartments distributed throughout the regions, is provided and applied to the body extremity. Each of the compartments of the plurality of compartments are capable of selective pressurization and depressurization. The body extremity is prepared for receipt of lymph fluid via a first pressurization and depressurization sequence of select compartments within select regions of the regions of the wrap, and lymph fluid is drained from the body extremity via a second pressurization and depressurization sequence of select compartments within select regions of the regions of the wrap, whereby the lymphatic system is stimulated so as to promote readsorption of pooled lymph fluid within surrounding tissue.
Owner:TACTILE SYST TECH

Method and device for treatment of edema

A therapeutic pad system (200) is disclosed for the treatment of edema, wherein the pressure applied to the user by the pad encourages the proximal flow of lymph. A fluid is provided to one or more bladder-type pads (220) in the pad through an inlet port (218) at a distal end of the pad, and is expelled from the bladder through an outlet port (220) at the proximal end of the bladder, thereby producing a pressure gradient across the pad. The system includes a flexible and compressible liner (250) filled with a number of small foam pieces (258) that is adapted to be wrapped about the therapeutic pad, and a relatively rugged, outer binder (270) that is securable about the liner (250). An advantage of the present system is that it may be applied in a number of different modes and combinations providing many treatment options.
Owner:DIANA RICHARD

Lymphedema treatment system

A method of body manipulation in furtherance of treating lymphedema is provided. A wrap, adapted to fit about a body extremity and having a trunk region, and limb regions, and a plurality of compartments distributed throughout the regions, is provided and applied to the body extremity. Each of the compartments of the plurality of compartments are capable of selective pressurization and depressurization. The body extremity is prepared for receipt of lymph fluid via a first pressurization and depressurization sequence of select compartments within select regions of the regions of the wrap, and lymph fluid is drained from the body extremity via a second pressurization and depressurization sequence of select compartments within select regions of the regions of the wrap, whereby the lymphatic system is stimulated so as to promote readsorption of pooled lymph fluid within surrounding tissue.
Owner:TACTILE SYST TECH

Integrated body fluid collection and analysis device with sample transfer component

A single, integrated device in which a body fluid (e.g., blood) of a human or animal can be both collected and analyzed easily and without risk of contamination is disclosed. The collection portion and analysis portion of the device are permanently joined to permit movement of small quantities of body fluid under controlled conditions, to minimize any waste of the body fluid, to ensure that no contamination reaches the main body fluid volume, and to create a permanent physical record of the results of the analysis in association with the fluid sample itself: A wide variety of different body fluid components which may be indicative of various diseases, dysfunctions and abnormalities of the human or animal or the body fluid itself can be tested for. The device includes a container for collecting human or animal body fluid, one or more testing chambers containing one or more analysis units activated by body fluid; a transfer pump or vacuum assembly to transfer one or more samples into the analysis units; and one-way valves or the equivalent to prevent any portion of the withdrawn sample from being returned to the collection container. The body fluid acted upon may be blood, blood plasma, urine, bile, pleural fluid, ascites fluid, stomach or intestine fluid, colostrom, milk or lymph.
Owner:AALTO SCI

System for correction of a biological fluid

A system is presented for correction of a patient's biological fluid, such as his blood, lymph or spinal fluid, containing various low-, medium- and high-molecular toxins. The system comprises an extracorporeal flow line in the form of a flexible tube interconnected between outlet and inlet means attached to appropriate location(s) on a patient's body. A small amount of the biological fluid, i.e., substantially not exceeding 100 ml, substantially continuously flows through the tube, and is mixed with magneto-conductive particles capable of adsorbing the various toxins. An obtained mixture of the biological fluid with the particles passes through a magnetic field region, and substantially all of the magneto-conductive particles are retained therein. Particle-free biological fluid is then returned into the patient's body through the inlet means.
Owner:IDIALIZA

Methods affecting markers in patients having vascular disease

Marker levels and forms can be modulated in patients having vascular disease when sufficient vascular tissue is removed. The markers can be, e.g., from tissue, blood or lymph. The markers are typically involved in molecular pathways which are in turn modulated. Atherectomy catheters are used for accomplishing sufficient removal of vascular tissue to effect the modulations.
Owner:TYCO HEALTHCARE GRP LP

Drainage devices and methods for use

ActiveUS20120029466A1Accurately indicatedSafe and minimally invasive methodStentsWound drainsCatheterThoracic cavity
Devices and methods for draining excess lymph fluid are disclosed. The device can be fixed to the blood vessel adjacent to the thoracic duct. The device can have a port for withdrawing lymph fluid exiting the thoracic duct. The device can have a cannula and / or subcutaneous port to draw the lymph fluid away from the thoracic duct and reduce hemostatic pressure in the lymphatic system.
Owner:LXS LLC +1

Automated Determination of Lymph Nodes in Scanned Images

Techniques include automatically detecting a lymph node in a scanned image of a body without human intervention, using one or more of three approaches. First, a subset of scanned images is determined, which belongs to one anatomical domain. A search region for lymph tissue is in a particular spatial relationship outside an anatomical object in the domain. Second, scanned images are segmented without human intervention to determine a boundary of a particular lymph node. The scanned images and outline data are received. Some of these embodiments automatically segment by determining an external marker, based on the outline data, and an internal marker, based on a geometric center of the outline data or thresholds determined automatically inside detected edges, or both, for a marker-controlled watershed algorithm. Third, based on lymph node data at a particular time, a second scanned image at a different time is segmented automatically, without human intervention.
Owner:THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK

Diagnostic imaging of lymph structures

In accordance with the present invention, there are provided methods for identifying the sentinel lymph node in a drainage field for a tissue or organ in a subject. In select embodiments, the invention allows for the identification of the first or sentinel lymph node that drains the tissue or organ, particularly those tissues associated with neoplastic or infectious diseases and disorders, and within the pertinent lymph drainage basin. Once the drainage basin from the tissue or organ, i.e., the sentinel lymph node, is identified, a pre-operative or intraoperative mapping of the affected lymphatic structure can be carried out with a contrast agent. Identification of the first or sentinel lymph node, on the most direct drainage pathway in the drainage field, can be accomplished by a variety of imaging techniques, including ultrasound, MRI, CT, nuclear and others. Moreover, once the lymphatic structure is identified as being associated with neoplastic or infectious diseases and disorders, the affected lymphatic structure can be removed surgically or by a suitable minimally invasive procedure to allow pathological analysis to be performed to determine whether certain diseases or disorders exist, without resort to more radical lymphadenectomy. Further, the agent can be made to carry diagnostic or therapeutic probes to be activated and / or delivered to the injection site or any part of the lymphatic pathway downstream from the injection site.
Owner:RGT UNIV OF CALIFORNIA

Methods for identifying, diagnosing, and predicting survival of lymphomas

Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.
Owner:HEALTH & HUMAN SERVICES NAT INST OF HEALTH GOVERNMENT OF THE UNITED STATES OF AMERICA THE DEPT OF

Enhancing lymph channel development and treatment of lymphatic obstructive disease

Disclosed and claimed are compositions and methods for therapy and / or prevention of lymphedema. The compositions can include an agent that induces development of lymphatic channels or lymphangiogenesis, such as, VEGF-C and / or that which stimulates VEGF-C expression and / or that which stimulates VEGF-C expression or that which stimulates its interaction or that which stimulates other pathways to so stimulate the development of lymphatic channels or lymphangiogenesis or that which stimulates along any point of or any molecules involved in the signal transduction pathway leading to lymphangiogenesis or lymph channel development (and / or vector(s) expressing one or more of these agent(s)). Embodiments can include kits.
Owner:EPSTEIN STEPHEN E

Lymphedema treatment system

A method of body manipulation in furtherance of treating lymphedema is provided. A wrap, adapted to fit about a body extremity and having a trunk region, and limb regions, and a plurality of compartments distributed throughout the regions, is provided and applied to the body extremity. Each of the compartments of the plurality of compartments are capable of selective pressurization and depressurization. The body extremity is prepared for receipt of lymph fluid via a first pressurization and depressurization sequence of select compartments within select regions of the regions of the wrap, and lymph fluid is drained from the body extremity via a second pressurization and depressurization sequence of select compartments within select regions of the regions of the wrap, whereby the lymphatic system is stimulated so as to promote readsorption of pooled lymph fluid within surrounding tissue.
Owner:TACTILE SYST TECH

Methods and apparatus for transesophageal microaccess surgery

The current invention describes methods of transesophageal access to the neck and thorax to perform surgical interventions on structures outside the esophagus in both the cervical and the thoracic cavity. It describes a liner device made of a complete or partial tubular structure, or a flat plate, the liner having means to facilitate creation of a side opening, which may include a valve. The liner with its side opening form a port structure inside the esophageal lumen. The port structure allows elongated surgical devices to pass through a perforation across the full thickness of the esophageal wall to outside location, in a controlled way. The elongated surgical devices can be diagnostic scopes, therapeutic scopes, manual elongated surgical devices, robotic arms or the like. After being deployed outside the esophagus, the surgical devices can access structures outside the esophagus, in the neck and thorax in 360 degrees of freedom around the esophageal circumference. These structures can be bony, cartilaginous, spinal, vascular, soft tissue, deep tissues, lymph nodal, cardiac, pulmonary, tracheal, nervous, muscular or diaphragmatic, skin and subcutaneous tissues of the neck, skin and subcutaneous tissues of the anterior chest wall, skin and subcutaneous tissues of the skin of the back, and skin and layers of the breast.
Owner:MICROACCESS

Diagnostic imaging of lymph structures

In accordance with the present invention, there are provided methods for identifying the sentinel lymph node in a drainage field for a tissue or organ in a subject. In select embodiments, the invention allows for the identification of the first or sentinel lymph node that drains the tissue or organ, particularly those tissues associated with neoplastic or infectious diseases and disorders, and within the pertinent lymph drainage basin. Once the drainage basin from the tissue or organ, i.e., the sentinel lymph node, is identified, a pre-operative or intraoperative mapping of the affected lymphatic structure can be carried out with a contrast agent. Identification of the first or sentinel lymph node, on the most direct drainage pathway in the drainage field, can be accomplished by a variety of imaging techniques, including ultrasound, MRI, CT, nuclear and others. Moreover, once the lymphatic structure is identified as being associated with neoplastic or infectious diseases and disorders, the affected lymphatic structure can be removed surgically or by a suitable minimally invasive procedure to allow pathological analysis to be performed to determine whether certain diseases or disorders exist, without resort to more radical lymphadenectomy. Further, the agent can be made to carry diagnostic or therapeutic probes to be activated and / or delivered to the injection site or any part of the lymphatic pathway downstream from the injection site.
Owner:RGT UNIV OF CALIFORNIA

Drainage devices and methods for use

ActiveUS9682223B2Accurately indicatedSafe and minimally invasive methodStentsWound drainsThree vesselsLymph fluid
Devices and methods for draining excess lymph fluid are disclosed. The device can be fixed to the blood vessel adjacent to the thoracic duct. The device can have a port for withdrawing lymph fluid exiting the thoracic duct. The device can have a cannula and / or subcutaneous port to draw the lymph fluid away from the thoracic duct and reduce hemostatic pressure in the lymphatic system.
Owner:LXS LLC +1

Multispectral light-splitting fused surgical operation guide system

The invention belongs to the technical field of operating field target qualitative positioning for surgical operation, and particularly relates to a multispectral light-splitting fused surgical operation guide system, which is used for solving the problem that a target cannot be distinguished existing in a tumor qualitative positioning technology for surgical operation in the conventional intranperative imaging technology. The multispectral light-splitting fused surgical operation guide system comprises a light source part, a light-splitting image pick-up part and an image fusing part, wherein the light source part comprises an annular white-light LED (Light-Emitting Diode) and a near infrared LED; the light-splitting image pick-up part comprises a near focus lens, a light splitting lens,a relay lens, an optical filter and a lens barrel; and the image fusing part comprises a plurality of video decoders which are connected with the signal output end of a near infrared and color image-pickup CCD (Charge-Coupled Device) respectively. The multispectral light-splitting fused surgical operation guide system has the beneficial effects that: an anatomical color image of an operating field and a near infrared optical image which cannot be seen by naked eyes are shot respectively by adopting spectroscopic photography, and are displayed respectively; and image fusing is adopted, so thatblood vessels, lymph vessels, lymph nodes and fluorescent dye-marked tumor tissues in the operating field can be accurately positioned and displayed.
Owner:TIAYUAN SAI & SCI & TECH DEVCO

Hyperthermia and immunotherapy for leukemias lymphomas, and solid tumors

An improved method of inducing whole-body hyperthermia and enhanced anti-tumor immune response through inoculation of a fever virus with nil mortality and subsequent injection of irradiated tumor cells derived from the patient. This therapy will safely reduce the tumor burden by 90-99.9% by physical means (fever), before raising interferon levels to over 250 times baseline. The Activated Lymphokine Killer cells produced by these high interferon levels are capable of killing any cell expressing viral or tumor antigens, even those which had previously escaped immune surveillance. As a final step in the process, a specific class of Cytotoxic T Lymphocytes programmed to destroy the patient's own cancer cells will be produced by repeated inoculation of irradiated cancer cells harvested from the patient. Through a combination of three methods of therapy never previously integrated into a single regimen, it is logical to state that this therapy has a high probability of completely eradicating cancer cells from the patient. In addition, this therapy provides for life-long immunity to the reoccurrence of the disease.
Owner:RANDY K BROWN +1

Method for pressure mediated selective delivery of therapeutic substances and cannula

InactiveUS20080269718A1Reduce deliveryPermit deliveryStentsCannulasWhole bodyControl substances
Methods and devices are disclosed for selective delivery of therapeutic substances to specific histologic or microanatomic areas of organs. Introduction of the therapeutic substance into a hollow organ space (such as an hepatobiliary duct or the gallbladder lumen) at a controlled pressure, volume or rate allows the substance to reach a predetermined cellular layer (such as the ephithelium or sub-epithelial space). The volume or flow rate of the substance can be controlled so that the intralumenal pressure reaches a predetermined threshold level beyond which subsequent subepithelial delivery of the substance occurs. Alternatively, a lower pressure is selected that does not exceed the threshold level, so that delivery occurs substantially only to the epithelial layer. Such site specific delivery of therapeutic agents permits localized delivery of substances (for example to the interstitial tissue of an organ) in concentrations that may otherwise produce systemic toxicity. Occlusion of venous or lymphatic drainage from the organ can also help prevent systemic administration of therapeutic substances, and increase selective delivery to superficial epithelial cellular layers. Delivery of genetic vectors can also be better targeted to cells where gene expression is desired. The access device comprises a cannula with a wall piercing tracar within the lumen. Two axially spaced inflatable balloons engage the wall securing the cannula and sealing the puncture site. A catheter equipped with an occlusion balloon is guided through the cannula to the location where the therapeutic substance is to be delivered.
Owner:DEPT OF HEALTH & HUMAN SERVICE THE GOVERNMENT OF THE US SEC

Air wave pressure therapeutic apparatus

The invention discloses an air wave pressure therapeutic apparatus. The air wave pressure therapeutic apparatus comprises a host machine, multi-cavity air bags and air connecting pipes for connecting the hose machine with the multi-cavity air bags. The host machine is connected with the multi-cavity air bags through the air connecting pipes into a whole. An air wave control circuit, an input module, an output module, a displaying module and a power module are arranged in the host machine. The input module, the output module, the displaying module and the power module are connected with the air wave control circuit. A power indicator lamp, a displaying device, an adjustment knob, mode selecting buttons, an external connection power input jack and a power switch are arranged on the front face of the host machine. According to the air wave pressure therapeutic apparatus, due to sequential repeated inflating and deflating of the multi-cavity air bags, the circulating pressure on limbs and tissues is formed, even and sequential pressing is carried out on the portions from the far ends of the limbs to the near ends of the limbs, the effects of promoting flowing of blood and lymph and improving microcirculation are achieved, thrombi are easily prevented, limb edema is prevented, and multiple diseases related to blood and lymph circulation can be directly or indirectly treated.
Owner:LIANYUNGANG FUYUAN MEDICAL INSTR

Therapeutic Device For Inducing Blood Pressure Modulation

A Kinetic Recliner Chair apparatus intended for use both as a recliner chair and as an apparatus for enhancing blood circulation, and lymph and neural fluid flow throughout a person's body. In order to utilize the apparatus in its therapeutic mode, a person fully reclines a reclining chair member thereof and then activates a controllable motor driven drive mechanism that cyclically tilts the reclining chair member like a seesaw, which action alternatively raises the person's upper torso and head above his or her lower extremities, and vice-versa.
Owner:VBPM LIABILITY CORP

Method and apparatus for electromagnetic human and animal immune stimulation and/or repair systems activation

A method and device that can deliver a time-varying electric field non-invasively inside of biological tissue and / or biological fluid such as blood and / or lymph and / or synovial fluid and / or interstitial fluid and / or other fluids in-vivo and with magnitudes that do not cause a tolerable amount of neural motor and sensory action potential generation and frequency components below the megahertz range by means of the placement of more than one electrode on the skin with or without some intermediate biological, synthetic, or natural agent or substance between the electrode and the skin and / or by induction by means of a time-varying magnetic field or both with the novel purpose of activation and / or potentiation and / or normalization and / or regulation and / or stimulation and / or signaling and / or increase and / or regulation of the alertness and / or self tuning of the immune system or any of its parts or components directly or indirectly, locally and / or globally with the purpose of pathogen load reduction and / or reduction of the disease symptoms and / or clinical improvement and / or tumor size reduction and / or malignancy reduction or amelioration and / or improvement of the effects of an autoimmune disorder or any other related condition that could be treated or remised by its effects.
Owner:PORTELLI LUCAS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products